Literature DB >> 16476810

Incidence and causes of nondegenerative nonvascular dementia: a population-based study.

David S Knopman1, Ronald C Petersen, Ruth H Cha, Steven D Edland, Walter A Rocca.   

Abstract

BACKGROUND: Information on the incidence of nondegenerative and nonvascular dementia is limited.
DESIGN: We used the records-linkage system of the Rochester Epidemiology Project to ascertain incident cases of dementia in Rochester, Minn, from January 1, 1990, through December 31, 1994. To define causes of dementia, we reviewed all diagnoses, imaging study results, laboratory test results, and clinical courses, as recorded historically in the patient dossier.
RESULTS: We found 560 incident cases of dementia, and 60 of them (10.7%) had onset before the age of 70 years (younger-onset group). Forty-three cases (7.7%) were due to nondegenerative nonvascular causes and represented 30.0% of the total in the younger-onset group, but only 5.0% of the total in the older-onset group (aged 70-99 years). The most common nondegenerative nonvascular causes were cancer with or without brain metastases (n = 13), chronic alcoholism (n = 7), and chronic mental illness (n = 11). There were no cases of dementia due to normal-pressure hydrocephalus, subdural hematoma, hypothyroidism, vitamin B12 deficiency, or neurosyphilis. There were 2 individuals with acute confusion due to subdural hematoma and 1 with hypothyroidism whose cognition normalized with therapy.
CONCLUSIONS: Nondegenerative nonvascular causes were more common than expected in patients with a younger onset of dementia. None of the patients with dementia reverted to normal with treatment of the putative reversible cause.

Entities:  

Mesh:

Year:  2006        PMID: 16476810     DOI: 10.1001/archneur.63.2.218

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

1.  Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging.

Authors:  David S Knopman; Rosebud O Roberts; V Shane Pankratz; Ruth H Cha; Walter A Rocca; Michelle M Mielke; Bradley F Boeve; Eric G Tangalos; Robert J Ivnik; Yonas E Geda; Ronald C Petersen
Journal:  Am J Epidemiol       Date:  2014-05-23       Impact factor: 4.897

2.  Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States.

Authors:  Walter A Rocca; Ronald C Petersen; David S Knopman; Liesi E Hebert; Denis A Evans; Kathleen S Hall; Sujuan Gao; Frederick W Unverzagt; Kenneth M Langa; Eric B Larson; Lon R White
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

3.  Passive case-finding for Alzheimer's disease and dementia in two U.S. communities.

Authors:  David S Knopman; Ronald C Petersen; Walter A Rocca; Eric B Larson; Mary Ganguli
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

Review 4.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

5.  Prevention of dementia.

Authors:  Rodolfo Savica; Ronald C Petersen
Journal:  Psychiatr Clin North Am       Date:  2011-03

6.  Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA).

Authors:  Badri N Vardarajan; Kelley M Faber; Thomas D Bird; David A Bennett; Roger Rosenberg; Bradley F Boeve; Neill R Graff-Radford; Alison M Goate; Martin Farlow; Robert A Sweet; Rafael Lantigua; Martin Z Medrano; Ruth Ottman; Daniel J Schaid; Tatiana M Foroud; Richard Mayeux
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

Review 7.  Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.

Authors:  Peter T Nelson; Heiko Braak; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2009-01       Impact factor: 3.685

Review 8.  Spectrum of cognition short of dementia: Framingham Heart Study and Mayo Clinic Study of Aging.

Authors:  David S Knopman; Alexa Beiser; Mary M Machulda; Julie Fields; Rosebud O Roberts; V Shane Pankratz; Jeremiah Aakre; Ruth H Cha; Walter A Rocca; Michelle M Mielke; Bradley F Boeve; Sherral Devine; Robert J Ivnik; Rhoda Au; Sanford Auerbach; Philip A Wolf; Sudha Seshadri; Ronald C Petersen
Journal:  Neurology       Date:  2015-10-09       Impact factor: 9.910

Review 9.  Normal pressure hydrocephalus: diagnosis and treatment.

Authors:  David Shprecher; Jason Schwalb; Roger Kurlan
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

10.  Anesthesia and incident dementia: a population-based, nested, case-control study.

Authors:  Juraj Sprung; Christopher J Jankowski; Rosebud O Roberts; Toby N Weingarten; Andrea L Aguilar; Kayla J Runkle; Amanda K Tucker; Kathryn C McLaren; Darrell R Schroeder; Andrew C Hanson; David S Knopman; Carmelina Gurrieri; David O Warner
Journal:  Mayo Clin Proc       Date:  2013-05-01       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.